Información adicional

• Num_publicacion 76(3-4)
• Resumen_ingles

  Antituberculous drug-induced liver injury (ATDILI) is the most common and potentially serious adverse effect reported. Younger children, patients with extrapulmonary tuberculosis and children who are treated with high dosis of pyrazinamide are on serious risk for hepatotoxicity. There aren’t either consensus or specific recommendations about ATDILI in children. We report a case of tuberculous meningitis in a three year old girl who developed hepatotoxicity and provide some insight into its management. We performed a review of the published literature and made an update about management of ATDILI in paediatric patients.

• Palabras_clave_ingles Hepatotoxicity Antituberculous drugs DILI Pediatric patients
• Todos_autores J.M. Rius Peris¹, C. Rivas Juesas², A. Maraña Pérez¹, L. Hernández³
• autores listados J.M. Rius Peris, C. Rivas Juesas, A. Maraña Pérez, L. Hernández
• Correspondecia
  J.M. Rius Peris. Servicio de Pediatría. Hospital Virgen de la Luz. Hermandad de Donantes de Sangre, 1. 16002 Cuenca.
  Correo electrónico: riusjua@gmail.com
   
• Titulo_ingles Antituberculous drug-induced liver injury. What we have to do with pediatric patients?
• Centros_trabajo ¹Servicio de Pediatría. Hospital Virgen de la Luz. Cuenca. ²Servicio de Pediatría. Hospital de Sagunto. Valencia. ³Servicio de Radiodiagnóstico. Hospital Virgen de la Luz. Cuenca
• Publicado en Acta Pediatr Esp. 2018; 76(3-4): e41-e46
• copyright ©2018 Ediciones Mayo, S.A.
• Fecha recepcion 12/08/16
• Fecha aceptacion 7/12/16
• Tipo de Artículo Clínico (Microdatos) Case Reports